Evaluation and Modeling with the Therapeutic Effects Group
Members
Maîtresse de conférences - praticienne hospitalière
UCBL
Tel: 04 72 11 94 07
Maître de conférences - praticien hospitalier
UCBL
Tel: 33 04 72 32 34 87
Professeur des universités - médecin généraliste
UCBL
Tel: 04 78 74 18 18
Maîtresse de conférences
UCBL
Tel: 33 04 78 78 57 83
Professeure des universités - médecin généraliste
UCBL
Tel: 04 78 77 72 86
Professeur d'université - praticien hospitalier
UCBL
Tel: 04 72 44 81 42
Doctorante
HCL
Assistant hospitalier universitaire
UCBL
Doctorant
UCBL
Tel: 04 72 44 81 42
Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 16 80 99
Doctorante
autre
Tel: 04 72 44 81 42
Praticien hospitalier
HCL
Tel: 04 72 44 81 42
Professeur d'université - praticien hospitalier émérite
UCBL
Professeur d'université - praticien hospitalier
UCBL
Tel: 04 27 85 77 32
Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 78 86 33 01
Post-doc
UCBL
Maîtresse de conférences - praticienne hospitalière
UCBL
Maître de conférences - praticien hospitalier
UCBL
Tel: 04 72 11 94 20
Doctorante
UCBL
Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 12 94 37
Post-doc
UCBL
Doctorante
UCBL
Tel: 04 72 44 81 42
EMET presentation
The EMET team brings together doctors, pharmacists and research professors specializing in the evaluation and use of drug and non-drug therapies, around a single project built on two axes:
- the evaluation of therapies in clinical trials or observational studies;
- the construction of explanatory and predictive models, to better understand and therefore predict the effect of therapies, simulate their impacts at the individual and population level, and improve the innovation paradigm.
The EMET team is therefore part of two major dynamics in therapy: analysis of the level of evidence and precision medicine.
The fields of application are cardiovascular and metabolic diseases, primary care medicine, rare pediatric diseases (including genetic and autoimmune diseases), oncology and infectious diseases.
EMET members implement approaches using different mathematical models: direct comparison and network meta-analysis, pharmacokinetic/pharmacodynamic analysis, Bayesian networks and machine learning.
Education
The EMET team is specially involved in the teaching of pharmacology and therapeutics and the modeling of the treatment effect through the coordination of the Masters 2 Clinical Evaluation (EC) and Pharmacology modeling and clinical trials (PHAME), Interpretation of Therapeutic Trials (IET), Training of investigators in clinical drug trials (FIEC) and Training of clinical research assistants and clinical study technicians (FARCTEC). Teacher-researchers are also involved in the first (pharmacology), second (pharmacology / therapeutics, pharmacy) and third cycles (general medicine, pediatrics, internal medicine) in health training courses.
Society involvement
The members of the EMET team through their work and their interactions with the other components of the LBBE, National societies, governmental (HAS) or international (EMA) agencies, and the Hospices Civils de Lyon, are invested in current societal issues: rationalization of the use of health product resources, research ethics, gender equality, rationality of approaches in analyzing the diversity of human populations.
Publications
Display of 301 to 330 publications on 613 in total
Health related quality of life in infants and children with interstitial lung disease: a national pilot survey in France.
Congrès Francophone Pédiatrique de Pneumologie et d’Allergologie .
Poster
see the publicationHémosidérose idiopathique pulmonaire de l’enfant et trisomie 21: une étude nationale.
Congrès Francophone Pédiatrique de Pneumologie et d’Allergologie .
Poster
see the publicationAcute chest pain in an adolescent with cystic fibrosis in September: Would you have thought about this?
Pediatric Pulmonology . 52 ( 10 ) : E70-E72
DOI: 10.1002/ppul.23746
Journal article
see the publicationA simplified, semi-quantitative structural lung disease computed tomography outcome during quiet breathing in infants with cystic fibrosis
Journal of Cystic Fibrosis . 16 ( 1 ) : 151 - 157
Journal article
see the publicationAdding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors
Arthritis & rheumatology . 69 ( 11 ) : 2175 - 2186
DOI: 10.1002/art.40205
Journal article
see the publicationIsolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases
PLoS ONE . 12 ( 9 )
Journal article
see the publicationIntravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome
The American Journal of Medicine . 130 ( 10 ) : 1219.e19 - 1219.e27
Journal article
see the publicationA sudden death risk score specifically for hypertension
Journal of Hypertension . 35 ( 11 ) : 2178-2184
Journal article
see the publicationStrong incidence of pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa
PLoS ONE . 12 ( 3 ) : 1-19
Journal article
see the publicationProtocol of GLUcose COntrol Safety and Efficacy in type 2 DIabetes, a NETwork meta-analysis: GLUCOSE DINET protocol-Rational and design
Fundamental & Clinical Pharmacology . 31 ( 3 ) : 258-264
DOI: 10.1111/fcp.12263
Journal article
see the publicationEffet antalgique aigu du paracétamol en soins primaires : des preuves incomplètes
Thérapie . 72 ( 5 ) : 609 - 613
Journal article
see the publicationEfficiency of physical therapy on postural imbalance after stroke: study protocol for a systematic review and meta-analysis
BMJ Open . 7 ( 1 ) : e013348
Journal article
see the publicationThe Role of Antibiotics in Modulating Virulence in Staphylococcus aureus
Clinical Microbiology Reviews . 30 ( 4 ) : 887-917
DOI: 10.1128/CMR.00120-16
Journal article
see the publicationIs Trough Concentration of Vancomycin Predictive of the Area Under the Curve? A Clinical Study in Elderly Patients
Therapeutic Drug Monitoring . 39 : 83-87
Journal article
see the publicationImplications of using the MDRD or CKD-EPI equation instead of the Cockcroft-Gault equation for estimating renal function and drug dosage adjustment in elderly patients
Fundamental & Clinical Pharmacology . 31 : 110-119
DOI: 10.1111/fcp.12241
Journal article
see the publicationA Model for Predicting the Interindividual Variability of Drug-Drug Interactions
AAPS Journal . 19 : 497-509
Journal article
see the publicationSensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
Journal of pediatric endocrinology & metabolism . 30 : 27-35
Journal article
see the publicationEvaluation of haemodialysis as a protective technique for preventing high daily dose amikacin nephrotoxicity: an experimental study in an ovine model.
International Journal of Antimicrobial Agents .
Journal article
see the publicationEfficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials
Diabetes & Metabolism . 43 ( 1 ) : 48 - 58
Journal article
see the publicationNo benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials
PLoS ONE . 12 : e0171168
Journal article
see the publicationPopulation pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen
Journal of Antimicrobial Chemotherapy . 72 ( 10 ) : 2804-2812
DOI: 10.1093/jac/dkx242
Journal article
see the publicationMechanisms of drug-drug interaction between rifampicin and fusidic acid
British Journal of Clinical Pharmacology . 83 ( 8 ) : 1862-1864
DOI: 10.1111/bcp.13277
Journal article
see the publicationA Nonparametric Method to Optimize Initial Drug Dosing and Attainment of a Target Exposure Interval: Concepts and Application to Busulfan in Pediatrics
Clinical Pharmacokinetics . 56 : 435-447
Journal article
see the publicationPrevalence and Risk Factors of Drug-Associated Corrected QT Prolongation in Elderly Hospitalized Patients: Results of a Retrospective Analysis of Data Obtained Over 6 Months
Drugs & aging . 34 : 545-553
Journal article
see the publicationMathematical model of T-cell lymphoblastic lymphoma: disease, treatment, cure or relapse of a virtual cohort of patients
Mathematical Medicine and Biology .
Journal article
see the publicationPhone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the baclophone cohort study protocol
Expert Opinion on Drug Safety . 16 ( 2 ) : 125-132
Journal article
see the publicationProactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France
Drug Safety . 40 : 257-262
Journal article
see the publicationA Novel Analog Reasoning Paradigm: New Insights in Intellectually Disabled Patients
PLoS ONE . 11 ( 2 ) : e0149717
Journal article
see the publicationADHD in childhood epilepsy: Clinical determinants of severity and of the response to methylphenidate
Epilepsia . 57 : 1069-77
DOI: 10.1111/epi.13420
Journal article
see the publicationSafety study of Ciprofloxacin in newborn mice
Regulatory Toxicology and Pharmacology . 74 : 161-169
Journal article
see the publication
You also, comment on this article